Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

606 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. Bikdeli B, et al. Among authors: eikelboom jw. J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17. J Am Coll Cardiol. 2020. PMID: 32311448 Free PMC article. Review.
A replacement for warfarin: the search continues.
Eikelboom JW, Weitz JI. Eikelboom JW, et al. Circulation. 2007 Jul 10;116(2):131-3. doi: 10.1161/CIRCULATIONAHA.107.712349. Epub 2007 Jun 18. Circulation. 2007. PMID: 17576860 No abstract available.
Selective factor Xa inhibition for thromboprophylaxis.
Eikelboom JW, Weitz JI. Eikelboom JW, et al. Lancet. 2008 Jul 5;372(9632):6-8. doi: 10.1016/S0140-6736(08)60879-X. Epub 2008 Jun 24. Lancet. 2008. PMID: 18582929 No abstract available.
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk.
Eikelboom JW, Hankey GJ, Thom J, Bhatt DL, Steg PG, Montalescot G, Johnston SC, Steinhubl SR, Mak KH, Easton JD, Hamm C, Hu T, Fox KA, Topol EJ; Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Investigators. Eikelboom JW, et al. Circulation. 2008 Oct 21;118(17):1705-12. doi: 10.1161/CIRCULATIONAHA.108.768283. Epub 2008 Oct 6. Circulation. 2008. PMID: 18838564 Clinical Trial.
Otamixaban in acute coronary syndromes.
Eikelboom JW, Weitz JI. Eikelboom JW, et al. Lancet. 2009 Sep 5;374(9692):762-4. doi: 10.1016/S0140-6736(09)61529-4. Epub 2009 Aug 28. Lancet. 2009. PMID: 19717186 No abstract available.
New anticoagulants.
Eikelboom JW, Weitz JI. Eikelboom JW, et al. Circulation. 2010 Apr 6;121(13):1523-32. doi: 10.1161/CIRCULATIONAHA.109.853119. Circulation. 2010. PMID: 20368532 Review. No abstract available.
New antithrombotic agents--insights from clinical trials.
Paikin JS, Eikelboom JW, Cairns JA, Hirsh J. Paikin JS, et al. Among authors: eikelboom jw. Nat Rev Cardiol. 2010 Sep;7(9):498-509. doi: 10.1038/nrcardio.2010.101. Epub 2010 Jun 29. Nat Rev Cardiol. 2010. PMID: 20585330 Review.
606 results